Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Multiple-Ascending-Dose Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations

NCT05890729 is registered in ClinicalTrials.gov with Xentria, Inc. as lead sponsor.

NCT NCT05890729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05890729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Multiple-Ascending-Dose Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations
Lead sponsor
Xentria, Inc.
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
November 10, 2023
Completion date
October 31, 2026
Enrollment
32 (estimated)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary sarcoidosis